Anticholinergic Burden and Botulinum Toxin Needs after Deep Brain Stimulation in Adult and Pediatric Patients with Dystonia
Open Access
- 22 September 2025
- journal article
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (3) , 774-778
Abstract
Background: Anticholinergic medications and botulinum neurotoxin injections are established treatments for dystonia, yet they carry potential side effects and practical challenges. Deep brain stimulation (DBS) is offered in case of poor response to these approaches. Objectives: To assess the need for anticholinergic medications and botulinum neurotoxin injections in adult and pediatric patients at two specialized Canadian centers before and after DBS over the past 10 years. Methods: 58 patients were included analyzing data before, 6 and 12 months after DBS. Clinical assessment included the Toronto Western Spasmodic Torticollis Rating Scale and Fahn‐Marsden Dystonia Rating Scale. Anticholinergic burden was determined by the Anticholinergic Drug Scale (ADS). Results: Severity of cervical dystonia and ADS scores reduction were statistically significant after DBS. Anticholinergic medication and Botulinum Neurotoxin injections were discontinued a year after surgery in 28.8% and 72.4% of the patients, respectively. Conclusion: Simplification of anti‐dystonia treatments is another added benefit of DBS.Keywords
Funding Information
- University of Toronto
- University Health Network
This publication has 26 references indexed in Scilit:
- Changes in Anticholinergic Burden in Parkinson’s Disease After Deep Brain StimulationNeuromodulation: Technology at the Neural Interface, 2023
- Basic Tips: How Do I Start Programming Deep Brain Stimulation in Parkinson Disease Patients?Movement Disorders Clinical Practice, 2021
- The Child & Youth CompreHensIve Longitudinal Database for Deep Brain Stimulation (CHILD-DBS)Child's Nervous System, 2020
- Medication use in childhood dystoniaEuropean Journal of Paediatric Neurology, 2016
- Development of the Comprehensive Cervical Dystonia Rating Scale: MethodologyMovement Disorders Clinical Practice, 2015
- Cognitive function in children with primary dystonia before and after deep brain stimulationEuropean Journal of Paediatric Neurology, 2015
- Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: A 20-year follow-upToxicon, 2014
- Dystonia rating scales: Critique and recommendationsMovement Disorders, 2013
- The Anticholinergic Risk Scale and Anticholinergic Adverse Effects in Older PersonsArchives of internal medicine (1960), 2008
- Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up studyThe Lancet Neurology, 2007